Carcinogens in Tobacco and Their Role in Oral Cavity Carcinoma

Overview

Approximately 95% of cancers of the oral cavity are squamous cell carcinomas (oral SCC). Tobacco - both smoked and smokeless - is the single most important risk factor. The carcinogens differ slightly depending on whether tobacco is smoked or chewed.

Carcinogens in Tobacco: Oral Cavity-Specific

Robbins & Kumar provides a dedicated organ-specific table of tobacco carcinogens (Robbins & Kumar Basic Pathology, Table 7.4):

Form of Tobacco	Carcinogens
Smoking	Polycyclic aromatic hydrocarbons (PAHs), Nicotine-derived nitrosamine ketone (NNK), N'-Nitrosonornicotine (NNN)
Chewing tobacco	NNK, NNN, ²¹⁰Polonium

Key Carcinogens Explained

Polycyclic Aromatic Hydrocarbons (PAHs) - e.g., benzopyrene
- Generated by combustion of tobacco
- Metabolized by cytochrome P450 enzymes into reactive epoxide intermediates
- These intermediates form bulky DNA adducts at guanine bases
- Result: point mutations in critical oncogenes and tumor suppressor genes (especially TP53)
Tobacco-Specific Nitrosamines (TSNAs)
- NNK (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) - present in both smoked and smokeless tobacco
- NNN (N'-nitrosonornicotine) - particularly high in smokeless/chewing tobacco
- Mechanism: nitrosamines are metabolically activated to methylating and pyridyloxobutylating agents that alkylate DNA (O6-methylguanine), leading to G→A transition mutations and miscoding
²¹⁰Polonium - a radioactive alpha-emitter present in smokeless tobacco; causes direct DNA strand breaks
Nicotine - not directly a carcinogen, but acts as a tumor promoter - stimulates nicotinic acetylcholine receptors, activates anti-apoptotic pathways, and promotes angiogenesis and tumor cell proliferation
Phenol - another tumor promoter found in tobacco tar; causes mucosal irritation and promotes initiated cells

Mechanism of Carcinogenesis in Oral Cavity

Step 1 - Initiation (DNA Mutation)

PAHs and nitrosamines are metabolized in oral mucosal epithelial cells. The reactive metabolites form DNA adducts, causing:

TP53 mutations (most common) - loss of apoptosis and cell cycle arrest
RAS gene mutations - uncontrolled proliferation
NOTCH gene mutations - impaired squamous differentiation

DNA sequencing of tobacco-associated oral cancers consistently shows a mutational signature characteristic of carcinogen exposure.

Step 2 - Field Cancerization

Years of chronic mucosal exposure to tobacco carcinogens lead to the concept of "field cancerization" - multiple independent neoplastic clones develop across wide areas of the oral mucosa. This explains:

Multiple simultaneous primary tumors
Development of new primary tumors at 3-7% per year after initial diagnosis

Step 3 - Precancerous Lesions

The carcinogen-induced mutations accumulate, producing:

Leukoplakia (white plaques) - 5-25% are dysplastic; tobacco use (including smokeless) is the most important risk factor
Erythroplakia (red velvety patches) - malignant transformation in >50% of cases
Both show a spectrum from hyperkeratosis → dysplasia → carcinoma in situ

Step 4 - Invasive Carcinoma

Fully established oral SCC shows:

Invasion through the basement membrane into connective tissue stroma
Histologically: nests and islands of malignant keratinocytes with keratin pearl formation (in well-differentiated tumors)
Preferential sites for carcinogen-associated cancers: ventral surface of tongue, floor of mouth, lower lip, soft palate, and gingiva

Gross and Histological Appearance

Oral SCC - Gross (A) shows ulceration and induration of oral mucosa; Histology (B) shows nests of malignant keratinocytes invading stroma with keratin pearls

FIG. 13.4 Oral squamous cell carcinoma. (A) Gross appearance - ulceration and induration of oral mucosa. (B) Histologic appearance - nests and islands of malignant keratinocytes invading the connective tissue stroma with keratin pearls.

Systemic Effects of Tobacco (broader context)

Health consequences of smoking - oropharynx, larynx, esophagus, and other organs labeled with associated cancers and chronic diseases

FIG. 7.9 Cancers and chronic diseases causally linked to smoking, including oropharynx, larynx, and esophagus.

Two Pathogenic Pathways of Oral SCC (Contrast)

Feature	Tobacco/Carcinogen-Associated	HPV-Associated
Main cause	Tobacco, alcohol, betel nut (paan)	High-risk HPV (especially HPV-16)
Mechanism	DNA adducts → TP53/RAS/NOTCH mutations	E6 inhibits p53; E7 inhibits RB
Mutation burden	High	Low
p16 expression	Absent/low	Overexpressed
Location	Ventral tongue, floor of mouth, lip	Tonsil, base of tongue
Response to immunotherapy	Good (high neoantigen burden)	Better prognosis overall

Clinical Features & Prognosis

Overall 5-year survival is only 50%, largely due to late diagnosis
Treated with surgery + radiation ± chemotherapy
Carcinogen-associated tumors respond to immune checkpoint inhibitors due to high tumor neoantigen burden
Tobacco cessation is the most effective primary prevention strategy

Sources: Robbins & Kumar Basic Pathology (Table 7.3, Table 7.4, pp. 540-541); Robbins, Cotran & Kumar Pathologic Basis of Disease; Goldman-Cecil Medicine.

This is a shared conversation. Sign in to Orris to start your own chat.